^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    m-ceNK cells

    i
    Associations
    News

    Trials

    Company:
    ImmunityBio
    Drug class:
    NK cell stimulant, IFNγ stimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT04898543)
    Phase 1
    ImmunityBio, Inc.
    Recruiting
    Last update posted :
    01/23/2024
    Initiation :
    06/21/2021
    Primary completion :
    06/21/2024
    Completion :
    12/31/2024
    CD4 • NKG2D
    |
    Anktiva (nogapendekin alfa inbakicept-pmln) • m-ceNK cells